Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 1
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Immunotherapy biomarkers
Original research
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
Online download statistics by month:
Online download statistics by month: January 2021 to February 2024
Abstract
Full
Pdf
Jan 2021
423
423
125
Feb 2021
271
273
96
Mar 2021
162
161
82
Apr 2021
89
89
77
May 2021
133
133
100
Jun 2021
111
111
68
Jul 2021
101
101
59
Aug 2021
112
112
54
Sep 2021
99
99
47
Oct 2021
91
91
61
Nov 2021
97
97
86
Dec 2021
110
110
58
Jan 2022
219
229
45
Feb 2022
44
52
38
Mar 2022
65
70
44
Apr 2022
87
115
64
May 2022
107
122
67
Jun 2022
133
136
71
Jul 2022
82
86
29
Aug 2022
83
89
61
Sep 2022
75
83
56
Oct 2022
71
81
63
Nov 2022
69
114
59
Dec 2022
63
65
36
Jan 2023
72
74
29
Feb 2023
85
85
29
Mar 2023
77
79
32
Apr 2023
50
51
30
May 2023
79
79
36
Jun 2023
38
38
24
Jul 2023
41
41
27
Aug 2023
24
24
18
Sep 2023
42
42
15
Oct 2023
32
32
19
Nov 2023
60
61
31
Dec 2023
70
70
37
Jan 2024
37
38
15
Feb 2024
44
44
38
Total
3648
3800
1926
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?